Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Venous Thromboembolism Clinical Trial

Official title:

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01598805
• Other study ID #: FZMI-KEK-ZH-Nr. 2010-0458
• Status: Completed
• Phase: N/A
• First received: May 11, 2012
• Last updated: November 15, 2012
• Start date: June 2012
• Est. completion date: September 2012

Study information

• Verified date: November 2012
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Interventional

Clinical Trial Summary

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.

Description:

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10000
• Est. completion date: September 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion criteria:

• all in-patients hospitalized in a ward with computerized physician order entry (CPOE),

• staying at least 24 h in a ward

Exclusion criteria:

• outpatients,

• ward without CPOE,

• patients transferred from an intervention to a control ward and vice versa

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Thromboembolism
• Venous Thromboembolism

Intervention

Behavioral:
• electronic alerts
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.

Locations

Country	Name	City	State
Switzerland	University Hospital Zurich, Center for Clinical Research	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of prophylaxis against venous thromboembolism	patients with prophylaxis/total patients	3 months	No
Secondary	ordering time after admission or transfer of a patient	time when physicians order a venous thromboembolism prophylaxis	3 months	No
Secondary	acceptance of the eAlerts	survey of compliant and incompliant physicians	3 months	No